IBYME   02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Neuroprotección por esteroides neuroactivos en modelos de neuropatologías
Autor/es:
DE NICOLA A.F.
Lugar:
Centro Cientifico-Tecnológico Mendoza, CONICET, 7-8 Abril 2009.
Reunión:
Simposio; Simposio “ Sistema neuroendócrino: Fisiopatología reproductiva, patología y envejecimiento”,; 2009
Institución organizadora:
CRICYT
Resumen:
&lt;!-- /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; mso-bidi-font-size:12.0pt; font-family:Arial; mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman"; mso-ansi-language:EN-US; mso-fareast-language:EN-US; mso-bidi-language:AR-SA;} @page Section1 {size:595.3pt 841.9pt; margin:70.85pt 2.0cm 70.85pt 2.0cm; mso-header-margin:35.45pt; mso-footer-margin:35.45pt; mso-paper-source:0;} div.Section1 {page:Section1;} --&gt; Progesterone (PROG) neuroprotection has been increasingly recognized in cases of central nervous system injury and neurodegeneration. Previous work has demonstrated beneficial effects of PROG in the Wobbler mouse, a model of motoneuron disease showing an autosomal recessive mutation in chromosome 11. PROG effects in this model may be due to direct actions on neuronal function, to antioxidant effects and to increase myelin synthesis by glial cells. Here, we show that the expression of BDNF mRNA analyzed by in situ hydridization (ISH) was increased by PROG treatment in ventral horn motoneurons from Wobbler mice. One month old clinically afflicted Wobbler mice were treated with a s.c. pellet of 20 mg PROG, and studied 60 days afterwards. Computerized image analysis to determine mRNA expression showed that the number of grains per unit area in neurons <600 um2 was decreased by 60% in steroid-naive Wobblers (9. 0 ± 1.31 vs control 30.0 ± 2, p<0.01) as well as in cells >600 μm2 (12.16 ± 1.51 vs. control 22.36 ± 0.72, p<0.01). In PROG-treated Wobblers, grain density increased 1.8-fold in neurons <600 μm2 (22.15 ± 2.0 , p<0.05 vs untreated Wobblers) and 1.9-fold in neurons >600 μm2 (17,27 ± 1.96, p<0.05 vs. untreated group). We also studied the activity of the enzyme choline acetyltransferase (ChAT) in nerve terminals, considering its close relationship to BDNF. Whereas ChAT activity was reduced by 55.3% in Wobbler mice, treatment with PROG induced a slight but statistically significant increment (p<0.05). Confocal microscopy images showed colocalization of BDNF and ChAT in motoneurons, and in these cells, the reduction of ChAT immunoreactivity of Wobblers was restored to normal by PROG. Finally, we investigated PROG effects on motoneuron morphology, which in untreated Wobblers show a typical vacuolar degeneration. Whereas some motoneurons in PROG-treated Wobbler mice still presented a vacuolated profile, it was not as marked as that in steroid-naive Wobblers; PROG treatment reduced 6-fold the percentage of vacuolated cells of Wobbler mice (p<0.05). Thus, PROG effects on neuronal BDNF could provide a trophic environment and might be part of the PROG activated-pathways to provide neuroprotection in neurodegenerative diseases (amyotrophic lateral sclerosis, spinal muscular atrophy).